Listed by the USPTO as GANGLE, BRIAN J
Tech Center 1600 • Art Units: 1636 1645 1647
This examiner grants 77% of resolved cases
GANGLE, BRIAN J is assigned to tech center 1600 and art unit 1636. The dataset includes 961 resolved cases, an allowance rate of 76.8%, and a median of 951 days to allowance. The extensive record indicates that allowance is the predominant recorded outcome, while the timing figure provides a practical expectation for successful prosecution. Interviews are associated with a 14.6% lift, making them useful when direct clarification can supplement a written response.
The principal companies are Pfizer Inc., Amazentis SA, and Dana-Farber Cancer Institute Inc. The leading firms are BAKER BOTTS L.L.P., BakerHostetler, and Brooks Kushman P.C. The company mix reflects pharmaceutical and biomedical portfolios. Counsel can draw on the listed organizations for relevant prosecution context, while using claim-focused amendments and evidence to address the examiner’s technical concerns.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18114092 | USES OF UROLITHINS | Final Rejection | Amazentis SA |
| 18264136 | PROTEIN M ANALOGS AND FUSION PROTEINS AND THEIR USE FOR INHIBITING ANTIBODY FUNCTION | Non-Final OA | The University of North Carolina at Chapel Hill |
| 18682052 | EXOPOLYSACCHARIDE PRODUCTION MICROORGANISMS AND USES THEREOF | Non-Final OA | BASF SE |
| 18566497 | MINICELLS FROM HIGHLY GENOME REDUCED ESCHERICHIA COLI: CYTOPLASMIC AND SURFACE EXPRESSION OF RECOMBINANT PROTEINS AND INCORPORATION IN THE MINICELLS | Final Rejection | University of Virginia Patent Foundation |
| 19111208 | MICROORGANISM SIMULTANEOUSLY PRODUCING 1,3-PROPANEDIOL AND 3-HYDROXYPROPIONIC ACID, AND USE THEREOF | Non-Final OA | LG CHEM, LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy76.8% of resolved applications examined by Brian J Gangle were allowed (961 resolved cases), compared with 37.1% across Art Unit 1636 over the last five years.
This examiner's interview lift is +14.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Brian J Gangle took 951 days on average from filing to allowance.
Brian J Gangle examines applications in Art Unit 1636 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
